{"id":"766748ba-e7ce-4860-9603-2b77dde9e286","modelId":"2f847d21-9b21-4ce0-bb03-6d2bd97ae10b","versionId":null,"locationId":"aa8b9c05-c836-4021-801f-59801970401e","operatorId":null,"ownerId":null,"slug":"rewalk-7-united-states","status":"active","firstSeen":null,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://ir.golifeward.com/news-releases/news-release-details/fda-issues-clearance-rewalk-7-exoskeleton","title":"FDA Issues Clearance for ReWalk 7 Exoskeleton","sourceName":"Lifeward"},{"url":"https://golifeward.com/blog/lifewards-rewalk-personal-exoskeleton-now-covered-by-aetna-coverage-expands-to-include-three-of-the-largest-medicare-advantage-insurers/","title":"Lifeward's ReWalk Personal Exoskeleton Now Covered by Aetna","sourceName":"Lifeward"}],"notes":"ReWalk 7 (FDA cleared March 2025) is the latest generation personal exoskeleton for spinal-cord-injury users. Major reimbursement milestones in 2025-2026: UnitedHealthcare (Nov 2025), Humana (Dec 2025), and Aetna (Feb 2026) Medicare Advantage prior authorizations cover ~16M beneficiaries. CMS 2024 Home Health PPS Rule created lump-sum reimbursement pathway. June 2025 ALJ ruling established precedent that personal exoskeletons are 'reasonable and necessary.' Only FDA-cleared personal exoskeleton with stairs/curbs capability. Home use and clinical deployment across the US.","keyFacts":[{"label":"FDA clearance","value":"ReWalk 7 cleared March 2025"},{"label":"Medicare Advantage coverage","value":"Aetna (Feb 2026), Humana (Dec 2025), UnitedHealthcare (Nov 2025) — ~16M beneficiaries total"},{"label":"CMS pathway","value":"2024 Medicare Home Health PPS Rule placed personal exoskeletons in brace benefit category, effective Jan 1 2024"},{"label":"ALJ precedent","value":"June 2025: Administrative Law Judge ruled ReWalk 'reasonable and necessary' for Medicare beneficiary"},{"label":"Capability","value":"Only personal exoskeleton cleared for stairs and curbs"}],"reviewNote":null,"exposureHours":null,"exposureBasis":null,"customerSegment":null,"scaleTier":null,"contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-06-07T13:21:38.390Z","updatedAt":"2026-06-07T13:21:38.390Z","model":{"id":"2f847d21-9b21-4ce0-bb03-6d2bd97ae10b","companyId":"4421900a-d71f-407e-a37c-ad1e3905e97f","modelName":"ReWalk 7","slug":"rewalk-7","description":"Powered lower-limb personal exoskeleton; latest ReWalk generation, FDA cleared March 2025. Motor-driven powered gait for spinal-cord-injury users.","formFactor":"exoskeleton","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{"use":"medical (personal, SCI)","control":"weight-shift triggered powered gait","powered":"yes (motor-driven)","regulatory":"FDA cleared 2025-03","body_region":"lower-limb","availability":"commercial (2025 launch)"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://ir.golifeward.com/news-releases/news-release-details/fda-issues-clearance-rewalk-7-exoskeleton","title":"ReWalk 7 (FDA clearance 2025)","sourceName":"Lifeward (primary)"},{"url":"https://golifeward.com/","title":"Lifeward (official)","sourceName":"Lifeward (primary)"}],"aliases":["ReWalk 7"],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"createdAt":"2026-06-06T01:25:40.609Z","updatedAt":"2026-06-06T02:44:43.783Z","company":{"id":"4421900a-d71f-407e-a37c-ad1e3905e97f","name":"Lifeward","slug":"lifeward","description":"Powered medical exoskeleton maker; founded 2001 as ReWalk Robotics by Amit Goffer, rebranded to Lifeward in January 2024 (ticker RWLK to LFWD). The ReWalk personal exoskeleton enables paraplegic users to stand and walk.","status":"public (NASDAQ: LFWD; formerly ReWalk Robotics, RWLK)","founded":2001,"hq":"Yokneam, Israel","fundingTotal":null,"type":"hardware","reviewStatus":"reviewed","sources":[{"url":"https://ir.rewalk.com/news-releases/news-release-details/rewalk-robotics-transforms-company-identity-rebrands-lifeward","title":"Lifeward","sourceName":"Lifeward (primary)"},{"url":"https://golifeward.com/blog/rewalk-personal-exoskeleton-system-clearned-fda-home-use/","title":"ReWalk Personal 6.0 FDA home-use","sourceName":"Lifeward (primary)"}],"keyFacts":[],"aliases":["ReWalk Robotics","ReWalk"],"collisionRisk":"low","reviewNote":null,"createdAt":"2026-06-06T01:25:37.810Z","updatedAt":"2026-06-06T02:17:59.064Z"}},"version":null,"location":{"id":"aa8b9c05-c836-4021-801f-59801970401e","name":"United States","slug":"united-states","kind":"country","parentLocationId":null,"lat":null,"lng":null,"reviewStatus":"reviewed","aliases":["USA","US","United States of America"],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-05-30T22:00:33.148Z","updatedAt":"2026-05-30T22:00:33.148Z"},"operator":null,"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/rewalk-7-united-states","url":"https://registry.deploy.report/deployments/rewalk-7-united-states","name":"ReWalk 7 at United States","identifier":"766748ba-e7ce-4860-9603-2b77dde9e286","eventStatus":"https://schema.org/EventScheduled","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/united-states","name":"United States"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/lifeward","name":"Lifeward"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/rewalk-7","name":"ReWalk 7"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"exoskeleton","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":2,"primary_source_types":["primary-company-ir"]}}}